Northern Indiana Cancer Research Corsoortium, CCOP

描述（由申请人提供）： 北方印第安纳州癌症研究联合会（NICRC）的长期目标是促进社区参与国家癌症研究所（NCI）在印第安纳州和密歇根州赞助的临床试验。这包括促进癌症控制和治疗研究。六家医院和各种各样的医生，包括肿瘤学家，外科医生，专家和初级保健医生已经走到一起，支持这一奋进，并建立在彼此的资源和推广工作，以便为所有社区居民带来最好的护理。 在治疗癌症时，医生除了考虑最佳治疗方案外，还必须考虑许多因素。生活质量、保险、成本和时间限制只是癌症治疗所涉及的一些因素。在家附近接受治疗可以提高患者的生活质量，降低旅行成本，并有更多的时间与家人和朋友在一起。通过CCOP，NICRC能够提供最佳的治疗选择，同时允许患者在其家乡社区接受治疗。从参与临床试验中学到的科学在治愈癌症的斗争中是无价的，患者在离家近的地方接受治疗的能力是无价的。 除了治疗癌症，NICRC还致力于提高公众对癌症和早期发现的认识。通过癌症控制研究、报纸文章和公共广播公告，NICRC希望降低印第安纳州和密歇根州的癌症发病率和死亡率。

DESCRIPTION (provided by applicant): The long term objective of the Northern Indiana Cancer Research Consortium (NICRC) is to promote community participation in National Cancer Institute (NCI) sponsored clinical trials in Indiana and Michigan. This includes promotion of both cancer control and treatment studies. Six hospitals and a variety of physicians including oncologists, surgeons, specialists, and primary care physicians have come together to support this endeavor and to build on each others resources and outreach efforts in order to bring the best care to all community residents. When treating cancer, physicians have to consider numerous factors in addition to the best treatment options available. Quality of life, insurance, cost, and time constraints are just some of the elements involved with cancer treatment. Receiving treatment close to home provides patients with improved quality of life, decreased travel costs, and additional time to spend with family and friends. Through the CCOP, the NICRC is able to provide the best treatment options while allowing patients to receive treatment in their home communities. The science that is learned from participation in clinical trials is invaluable in the fight to cure cancer and the ability for patients to receive treatment close to home is priceless. In addition to treating cancer, the NICRC is also dedicated to increasing public awareness about cancer and early detection. Through cancer control studies, newspaper articles and public broadcast announcements, the NICRC hopes to decrease the incidence and mortality of cancer in Indiana and Michigan.